News | Mammography | January 12, 2016

Study determines women in their 40s most likely to experience false-positives

breast cancer screening, digital mammography, false positives, younger women, clinicl study, Annals of Internal Medicine

January 12, 2016 — False-positive results and additional imaging are common among younger women and women with risk factors for breast cancer who are screened with digital mammography. Biopsy occurs less often and rates of false-negative screening results are low. The analysis is published in Annals of Internal Medicine and was used to inform updated clinical practice recommendations from the U.S. Preventive Services Task Force (USPSTF).

Clinical guidelines recommend a personalized approach to mammography screening that takes into account individual risk factors for breast cancer, as well as the potential benefits and harms of screening. Researchers used registry data for more than 400,000 women aged 40 to 89 to estimate rates of false-positive and false-negative digital mammography results — and subsequent imaging and biopsies — among a general population of women undergoing screening with digital mammography. They found that false-positives and recommendations for additional imaging were highest among younger women (those aged 40 to 49 years). These rates decreased with age. Rates of false-negative results were generally low. Risk factors for breast cancer, such as positive family history, previous biopsy, high breast density and low body mass index for younger women, were associated with higher risk for false-positive result.

For more information: www.annals.org


Related Content

News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
Subscribe Now